More than 10 million children lost a parent or caregiver due to COVID-19
In a study from the University of Oxford and elsewhere, scientists found the number of children estimated to have experienced the death of a...
Antibodies from single COVID-19 booster decline 15% per month
In a study from The Ohio State University, scientists found neutralizing antibody levels against the original COVID-19 virus and omicron variants in vaccinated adults...
Why long COVID after mild infection could cause heart problems
Scientists from University Hospital Frankfurt found that persistent heart inflammation might explain heart symptoms in long COVID after mild SARS-CoV-2 infection.
After recovering from a...
WHO warns against two drugs for treating mild COVID-19
In a recent paper, scientists from WHO suggest that the antidepressant drug fluvoxamine and the gout drug colchicine are not recommended for patients with...
What you need to know about bivalent boosters for covid-19
The SARS-CoV-2 omicron variant has frustrated citizens and experts alike with its ability to evade immunity from vaccines and prior infections.
Fortunately, the FDA has...
Study shows the cause of long COVID symptoms
In a recent study, scientists from Western University found the cause of long COVID symptoms.
Many people who experience what is now called “long COVID”...
Heart inflammation after COVID-19 vaccines remains rare, study shows
In a Hadassah Ein Karem Medical Center study, scientists found that the risk of developing myocarditis among males ages 16 to 19 years was...
Scientists find 4th Pfizer vaccine can prevent severe COVID-19
In a recent study from Tel Aviv University, scientists found that the fourth dose of the BNT162b2 COVID-19 vaccine offers strong protection against severe...
The first Omicron-adapted COVID-19 boosters are coming
There has been a lot of discussion in the media about Omicron-adapted COVID-19 boosters, which are undergoing regulatory approval in several countries.
The new booster...
1 in 3 older COVID survivors get new diseases after infection
In a study from Optum Labs in Minnetonka, scientists found almost a third (32 of every 100) of older adults infected with COVID-19 developed...